Family Medicine Doctors in Fulton, MO Accepting Medicare

26 Family Medicine doctors found. Showing 21 - 26

Dr. Zachary Roberts Barker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 N Hospital Dr, Fulton, MO 65251 Phone: 573-642-5911    Fax: 573-642-3015

David Spadavecchia, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 110 N Hospital Dr, Fulton, MO 65251 Phone: 573-642-5911    Fax: 573-642-3015

Matthew R Mcclure, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10 S Hospital Dr, Fulton, MO 65251 Phone: 573-642-3376

Dr. Christine Marie White, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 110 N Hospital Dr, Fulton, MO 65251 Phone: 573-624-5911    Fax: 573-642-3015

Andrew Joseph Peterson, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 110 N Hospital Dr, Fulton, MO 65251 Phone: 573-642-5911    Fax: 573-642-3015

Jane Salutz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 110 N Hospital Dr, Fulton, MO 65251 Phone: 573-642-5911

News Archive

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

Defending health exchange's rollout puts Sebelius in the hot seat

Health and Human Services Secretary Kathleen Sebelius is being called to Capitol Hill by Republican lawmakers who want her to explain what went wrong with the Oct. 1 unveiling of healthcare.gov. She is also facing calls for her resignation. Still, according to Politico, her job is safe.

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

Takeda and Affymax provide update for Hematide in chemotherapy-induced anemia

Takeda Pharmaceutical Company Limited and Affymax, Inc. today announced their agreement to suspend co-development of Hematide to treat chemotherapy-induced anemia and to focus all development efforts for Hematide on the treatment of chronic kidney disease related anemia.

Chelsea Therapeutics announces $35 million in shares in registered public offering

Chelsea Therapeutics International, Ltd. announced today its intention, subject to market and other conditions, to offer $35 million in shares of its common stock in a registered public offering pursuant to its existing shelf registration statement.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)